DocumentCode
710805
Title
Unleashed DNA production for transfection, vaccines, or labeling
Author
Domach, M.M. ; Khan, S.A. ; Ataai, A.A.
Author_Institution
Dept. Chem. Eng., Carnegie Mellon, Pittsburgh, PA, USA
fYear
2015
fDate
17-19 April 2015
Firstpage
1
Lastpage
2
Abstract
To understand the limits of DNA synthesis and to improve the amount of plasmid DNA produced per growth process, we deregulated the replication of a plasmid that is not subject to antibiotic selection. To understand further what occurs within a host such as E. coli when deregulated plasmid replication occurs, the proteomes of wild-type and transformed cells were contrasted. We find the copy numbers of 15,000 or higher can be obtained for a 3.7 kB plasmid. Replication fidelity or host growth rate are not compromised. The proteomics suggests that among the adaptations are increased Krebs cycle activity and also factors that enable ribosomal assembly and function.
Keywords
DNA; RNA; cellular biophysics; molecular biophysics; proteins; proteomics; DNA synthesis; E. coli; Krebs cycle activity; antibiotic selection; growth process; host growth rate; plasmid DNA; plasmid replication; proteomes; proteomics; replication fidelity; ribosomal assembly; transfection; unleashed DNA production; vaccines; wild-type cells; Antibiotics; Assembly; DNA; Proteins; Proteomics; RNA; Vaccines;
fLanguage
English
Publisher
ieee
Conference_Titel
Biomedical Engineering Conference (NEBEC), 2015 41st Annual Northeast
Conference_Location
Troy, NY
Print_ISBN
978-1-4799-8358-2
Type
conf
DOI
10.1109/NEBEC.2015.7117038
Filename
7117038
Link To Document